Search results
Hepatitis on track to overtake TB as world’s biggest infectious killer
The Telegraph via Yahoo News· 2 months agoThe hepatitis B and C viruses are the most severe strains and, together, are the primary causes of...
What Is Hepatitis C (HCV)?
Verywell Health via Yahoo News· 1 year agoHepatitis C is an infection caused by the hepatitis C virus (HCV) that is mainly transmitted through shared needles. Hepatitis C causes few (if any)...
15 Best Drug Stocks To Invest In
Insider Monkey via Yahoo Finance· 7 months agoIn this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its...
3 Top Pharma Stocks to Buy Now: February 2024
InvestorPlace via Yahoo Finance· 4 months agoLooking for pharma stocks to buy in February 2024? The pharmaceutical industry has always drawn a big crowd of investors. It has a veritable laundry list...
There's A Real Chance To Stop This Miserable, Fatal Infection
HuffPost via Yahoo News· 7 months agoDying from hepatitis C is a notoriously miserable way to go. The virus attacks your liver ― in many...
Why NuCana Shares Are Rising Today?
Benzinga via Yahoo Finance· 2 years agoRegional Court of Dusseldorf has ruled in favor of NuCana plc (NASDAQ: NCNA), stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH infringed...
These 3 Stocks Are Rallying While the Rest of the Market Plunges
Motley Fool· 2 years agoThe broad market may be up a bit for the past few weeks. The bigger trend, however, remains bearish....
Gilead (GILD) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 1 year agoAlthough the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the...
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
Motley Fool· 11 months agoIf you're worried about the stock market crashing, then now is a good time to review your portfolio...
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoAtea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2023 Earnings Call Transcript May 8, 2023 Atea...
